Cargando…
The impact of national vaccination policy changes on influenza incidence in the Netherlands
BACKGROUND: We assessed the impact of two major modifications of the Dutch National Influenza Prevention Programme – the introduction in 1997 of free‐of‐charge vaccination to persons aged ≥65 years and to high‐risk groups (previously only advised, and not free of charge), and the lowering of the eli...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746562/ https://www.ncbi.nlm.nih.gov/pubmed/26648343 http://dx.doi.org/10.1111/irv.12366 |
Sumario: | BACKGROUND: We assessed the impact of two major modifications of the Dutch National Influenza Prevention Programme – the introduction in 1997 of free‐of‐charge vaccination to persons aged ≥65 years and to high‐risk groups (previously only advised, and not free of charge), and the lowering of the eligible age to 60 years in 2008 – on the estimated incidence of influenza infection leading to influenza‐like illness (ILI). METHODS: Additive negative‐binomial segmented regression models were fitted to ILI data from GP sentinel surveillance in two‐eight‐season intervals (1993/4 to 2000/1, 2004/5 to 2011/12, comparing pre‐ and post‐policy‐change periods within each interval), with laboratory virological reporting of samples positive for influenza or other ILI‐causing pathogens as covariates. RESULTS: For the 2008 policy change, there was a significant step decrease in influenza contribution considering all ages (=−111 per 100 positives; 95% CI: −162, −65·0), <60 years and 60–64 years age groups (B = −92·1 per 100; 95% CI: −134, −55·5; B = −5·2; 95% CI: −10·3, −1·2, respectively). There was no evidence for a decrease associated with the 1997 policy change targeting the ≥65 years age group. CONCLUSIONS: In the Netherlands, a 56% reduction in influenza contribution was associated with the 2008 policy targeting 60–64 year‐olds, but there was no effect of the earlier policy targeting ≥65‐year‐olds, for whom vaccination coverage was already rising before the policy change. |
---|